[Elsevier] Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial |
|
This post will be closed automatically in 2026-09-12 12:50
Reward10points
|
10
Generative Adversarial Network-based machine learning framework for mapping and predicting nanostructures distribution in nanoparticulate composites
10
Fabrication and performance study of Cr-doped SnO2/Ag/SnO2 multilayer transparent conductive films modified via thermal annealing
10
Adverse pregnancy outcomes and long-term cardiovascular disease risk
10
Advancing PTAA-based perovskite photovoltaics through ionic liquid interfacial engineering
10
Chemical oxidization of PTAA enables stable slot-die-coated perovskite solar modules
